Clinical trials: Manganese Safety in Pediatric Patients

Manganese Safety in Pediatric Patients

Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN

• Withdrawn
• Age: 3 to 17 years
• Phase 4

Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in pediatric patients >3 to 17 years of age requiring long-term parenteral nutrition.

Trial name

NCT05677126

Testing

Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid

Sponsor

American Regent, Inc.